Japanese Trademark — JPO

The mark consists of an abstract image of a bird made out of a circle, teardrops, and a square to the left of the word terns.

Application 2026350684 · 00

Quick Facts

Application Number	2026350684
Registration Number	1896655
Status	00
Mark (native)	The mark consists of an abstract image of a bird made out of a circle, teardrops, and a square to the left of the word terns.
Mark Type	madrid
Owner	Terns Pharmaceuticals, Inc.
Filed	2026-01-15
Registered	2025-11-12

Is this trademark active?

The mark consists of an abstract image of a bird made out of a circle, teardrops, and a square to the left of the word terns. has a current status of 00.

Goods & Services

The specification below is taken directly from the filed record at the Japan Patent Office for each Nice class this trademark covers.

Class 5 — Pharmaceuticals

Pharmaceutical preparations, namely, small-molecule drugs for the treatment of cancer, metabolic disorders, and endocrine disorders; pharmaceutical and biologic preparations for use in the treatment of oncology-related diseases and disorders; pharmaceutical and biologic preparations for use in the treatment of metabolic-related diseases and disorders; pharmaceutical and biologic preparations for use in the treatment of endocrine-related diseases and disorders; pharmaceutical and biologic preparations for use in the treatment of diabetes and obesity-related diseases and disorders; peptides for pharmaceutical purposes, namely, for the treatment of cancer, metabolic disorders, and endocrine disorders.

Class 42 — Scientific & IT Services

Pharmaceutical and biologic drug development services, namely, development of small-molecule drugs for use in humans; pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of oncology-related diseases and disorders; pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of metabolic-related diseases and disorders; pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of endocrine-related diseases and disorders; pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of diabetes and obesity-related diseases and disorders; research and development services in the field of pharmaceutical and biologic preparations; research and development services in the field of oncology-related diseases and disorders; research and development services in the field of metabolic-related diseases and disorders; research and development services in the field of endocrine-related diseases and disorders; research and development services in the fields of diabetes and obesity-related diseases and disorders; research and development services in the field of peptide pharmaceutical preparations; providing medical and scientific research information in the field of small-molecule drugs; providing medical and scientific research information in the field of clinical trials and post-market trials; providing medical and scientific research information in the field of oncology, metabolic, endocrine, diabetes, and obesity-related diseases and disorders.

Applicant

Name (romanised)

Terns Pharmaceuticals, Inc.

Timeline

Filed: 2026-01-15
Registered: 2025-11-12

About This Trademark

'The mark consists of an abstract image of a bird made out of a circle, teardrops, and a square to the left of the word terns.' is a 00 trademark on the Japan Patent Office register, owned by Terns Pharmaceuticals, Inc.. The application (2026350684) was filed on 15 January 2026 and registered on 12 November 2025.

This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services), specifically covering: Pharmaceutical preparations, namely, small-molecule drugs for the treatment of cancer, metabolic disorders, and endocrine disorders; pharmaceutical and biologic preparations for use in the treatment of oncology-related diseases and disorders; pharmaceutical and biologic preparations for use in the treatment of metabolic-related diseases and disorders; pharmaceutical and biologic preparations for use in the treatment of endocrine-related diseases and disorders; pharmaceutical and biologic preparations for use in the treatment of diabetes and obesity-related diseases and disorders; peptides for pharmaceutical purposes, namely, for the treatment of cancer, metabolic disorders, and endocrine disorders.; Pharmaceutical and biologic drug development services, namely, development of small-molecule drugs for use in humans; pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of oncology-related diseases and disorders; pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of metabolic-related diseases and disorders; pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of endocrine-related diseases and disorders; pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of diabetes and obesity-related diseases and disorders; research and development services in the field of pharmaceutical and biologic preparations; research and development services in the field of oncology-related diseases and disorders; research and development services in the field of metabolic-related diseases and disorders; research and development services in the field of endocrine-related diseases and disorders; research and development services in the fields of diabetes and obesity-related diseases and disorders; research and development services in the field of peptide pharmaceutical preparations; providing medical and scientific research information in the field of small-molecule drugs; providing medical and scientific research information in the field of clinical trials and post-market trials; providing medical and scientific research information in the field of oncology, metabolic, endocrine, diabetes, and obesity-related diseases and disorders.

Frequently Asked Questions

Who owns Japanese trademark 2026350684 ('The mark consists of an abstract image of a bird made out of a circle, teardrops, and a square to the left of the word terns.')?

Japanese trademark 2026350684 for the mark 'The mark consists of an abstract image of a bird made out of a circle, teardrops, and a square to the left of the word terns.' in Class 5, 42 is recorded on the Japan Patent Office register as owned by Terns Pharmaceuticals, Inc.. This covers one specific Japanese trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.

Is Japanese trademark 2026350684 currently a registered trademark?

No — the Japan Patent Office records the status of Japanese trademark 2026350684 for the mark 'The mark consists of an abstract image of a bird made out of a circle, teardrops, and a square to the left of the word terns.' as 00.

Which Nice classes is Japanese trademark 2026350684 registered under?

Japanese trademark 2026350684 for the mark 'The mark consists of an abstract image of a bird made out of a circle, teardrops, and a square to the left of the word terns.' is recorded in Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services). The filed specification reads: Class 5: Pharmaceutical preparations, namely, small-molecule drugs for the treatment of cancer, metabolic disorders, and endocrine disorders; pharmaceutical and biologic preparations for use in the treatment of oncology-related diseases and disorders; pharmaceutical and biologic preparations for use in the treatment…

When was Japanese trademark 2026350684 filed?

Japanese trademark 2026350684 for the mark 'The mark consists of an abstract image of a bird made out of a circle, teardrops, and a square to the left of the word terns.' was filed at the Japan Patent Office on 15 January 2026 and registered on 12 November 2025.

Data Source

Japan (Japan Patent Office)

Japanese trademark data is supplied by the Japan Patent Office (JPO) via the JPO open bulk data release. Official government publications in Japan are not subject to copyright under Article 13 of the Japanese Copyright Act. Local copy last synchronised on 2026-04-18.

The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.